Gabapentin Tablet
Product Images NDC 71335-0254

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-0254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1

A line graph comparing mean pain scores over 8 weeks between a placebo group and a Gabapentin group (3600 mg/day). The x-axis represents time in weeks, showing a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores, with Gabapentin scores decreasing over time and placebo scores remaining relatively steady.*

FDA Label Image

Figure2

Line chart showing mean pain scores over 7 weeks for three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, and the y-axis shows mean pain scores ranging from 0 to 10. The chart highlights a 3-week dose titration period followed by a 4-week fixed dose period, with pain scores decreasing for gabapentin groups compared to placebo.*

FDA Label Image

Figure3

A bar chart titled 'Proportion of Responders (patients with > 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo and gabapentin groups in two studies. Study 1 shows 12% responders for placebo and 29% for Gabapentin 3600 mg. Study 2 shows 14% responders for placebo, 32% for Gabapentin 1800 mg, and 34% for Gabapentin 2400 mg, with statistical significance indicators for gabapentin groups.*

FDA Label Image

Figure4

A scatter plot comparing differences (%) across three studies (Study a, Study b, Study c) relative to daily gabapentin dose (mg). The x-axis shows daily doses from 600 to 1800 mg, and the y-axis displays percentage differences from 2% to 22%. Each study is represented by different square markers: black for Study a, gray for Study b, and white for Study c, with percentage differences increasing with dose.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure diagram showing the molecular arrangement of the active ingredient gabapentin, featuring a cyclohexane ring with attached amino and carboxyl functional groups.*

FDA Label Image

Equation (Equation)

A text panel showing the formula for calculating creatinine clearance (CLCr) using age, weight, serum creatinine, and a factor for female patients. This formula is commonly used to estimate kidney function.*

FDA Label Image

Label Image (Lbl713350254)

Gabapentin 800 mg oral tablet label by Bryant Ranch Prepack. The label includes product name and strength, a comparison to Neurontin 800 mg tablet by Glenmark Pharmaceuticals Limited, quantity of 30 tablets, storage temperature instructions, a warning about dizziness, and a barcode. Lot number and NDC 71335-0254-1 are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.